Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment in Patients With Acute Ischemic Stroke

Clinical trial NCT07423975 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07423975
Sponsor: Beijing Tiantan Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stroke Acute Endovascular Treatment

Start date: 2026-03-01
Primary completion: 2026-09-30
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.